Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid
Grem, J.L.; Hoth, D.F.; Hamilton, J.M.; King, S.A.; Leyland-Jones, B.
Cancer Treatment Reports 71(12): 1249-1264
1987
ISSN/ISBN: 0361-5960 PMID: 3319136 Document Number: 286926
Document emailed within 1 workday
Related Documents
Schumacher, K. 2000: Comparison of fluorouracil + folinic acid, fluorouracil + levamisole and fluorouracil + folinic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04 Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(5): 239-240Klaassen, U.; Harstrick, A.; Wilke, H.; Seeber, S. 1996: Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer Seminars in Oncology 23(1 Suppl 1: 44-47
Chauffert, B.; Bonnotte, B.; Chvetzoff, G.; Flesch, M. 1998: The major response of metastatic kidney cancer to the combination of oxaliplatin, 5-fluorouracil and folinic acid (FOX-FOL) Presse Medicale 27(18): 859
Hiddemann, W.; Ruelfs, C.; Ottensmeier, C.; Rückle, H.; Musch, E.; Koch, O.; van de Loo, J. 1992: Interleukin-2 followed by fluorouracil and folinic acid in refractory colorectal cancer--results of a clinical phase Ii study Seminars in Oncology 19(2 Suppl 3: 225-227
Messadi, D.V.; Sato, K. 2016: Oral Cancer Chernoprevention: Current Status and Future Direction Journal of the California Dental Association 44(2): 101-111
Martin, D.S.; Kemeny, N.E. 1992: Overview of N-(phosphonacetyl)-L-aspartate + fluorouracil in clinical trials Seminars in Oncology 19(2 Suppl 3: 228-233
Osaki, A.; Saeki, T. 2011: Current status and future direction of postoperative adjuvant therapy in breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(9): 1406-1411
Khayat, D.; Gil-Delgado, M.; Antoine, E.C.; Coeffic, D.; Benhammouda, A.; Grapin, J.P.; Bastian, G. 1998: European experience with irinotecan plus fluorouracil/folinic acid or mitomycin Oncology 12(8 Suppl. 6): 64-67
Bernhard, H.; Klein, O.; Meyer zum Büschenfelde, K.H.; Knuth, A. 1992: Treatment of refractory colorectal carcinomas with fluorouracil, folinic acid, and interferon alfa-2a Seminars in Oncology 19(2 Suppl 3: 204-207
Lu, J.-w.; Zhou, Z.-f.; Yin, B.-j.; Liu, D.-l.; Feng, J.-f.; Zhu, L.-j.; Pan, L.-x. 2005: Chronomodulated chemotherapy of oxaliplatin, 5-fluorouracil and folinic acid for advanced gastric cancer Zhonghua Zhong Liu Za Zhi 27(11): 695-697
Ortiz, Z.; Shea, B.; Suarez-Almazor, M.E.; Moher, D.; Wells, G.A.; Tugwell, P. 1998: The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials Journal of Rheumatology 25(1): 36-43
Natoli, C.; Scognamiglio, M.T.; Martino, M.T.; Irtelli, L.; De Tursi, M.; Cianchetti, E.; Mascitelli, E.; Tinari, N.; Iacobelli, S. 2000: Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer Anticancer Research 20(2b): 1253-1256
Tsavaris, N.; Zinelis, A.; Karvounis, N.; Beldecos, D.; Mylonacis, N.; Zamanis, N.; Bacoyannis, C.; Valilis, P.; Antonopoulos, A.; Kosmidis, P. 1990: Multimodal biochemical modulation of 5-fluorouracil activity in advanced colorectal cancer with allopurinol, folinic acid and dipyridamol Journal of Chemotherapy 2(2): 123-126
Neyns, B.; Van Nieuwenhove, Y.; Aerts, M.; Fontaine, C.; Vermeij, J.; Schallier, D.; Decoster, L.; De Mey, J.; Vandenbroucke, F.; Hoorens, A.; Delvaux, G.; De Gréve, J. 2006: Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases Anticancer Research 26(1b): 611-619
Muggia, F.M.; Rozencweig, M.; Chiuten, D.F.; Jensen-Akula, M.S.; Charles, L.M.; Kubota, T.T.; Bono, V.H. 1980: Phase Ii trials: use of a clinical tumor panel and overview of current resources and studies Cancer Treatment Reports 64(1): 1-9
Slee, P.H.T.J.; Rodenburg, C.J.; Nortier, J.W.R.; van Bochove, A. 2004: A phase i dose-escalating study of docetaxel plus folinic acid and 5-fluorouracil in anthracycline-pretreated patients with metastatic breast cancer Netherlands Journal of Medicine 62(9): 314-319
Joshi, V.V. 1993: Pathology of pediatric AIDS. Overview, update, and future direction Annals of the new York Academy of Sciences 693: 71-92
Breul, J.; Tief, G.; Hartung, R. 1996: Enhancement of 5-fluorouracil cytotoxicity by folinic acid in different cell-lines of human renal cell carcinoma European Journal of Medical Research 1(7): 339-342
Colucci, G.; Maiello, E.; Leo, S.; Giuliani, F.; Pedicini, A.; Pezzella, G.; Valori, V.; Galetta, D.; Contillo, A.; Prete, F. 1994: Biochemical modulation of fluorouracil with high dose methotrexate or folinic acid in advanced colorectal cancer patients. Gruppo Oncologico dell' Italia Meridionale (GOIM) Anticancer Research 14(5b): 2157-2162
Lyttle, C.Richard.; Kopf, G.S. 2003: Status and future direction of male contraceptive development Current Opinion in Pharmacology 3(6): 667-671